Ratios in Focus: Analyzing Allogene Therapeutics Inc (ALLO)’s Price-to-Cash and Price-to-Free Cash Flow

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

In the latest session, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.13 down -4.24% from its previous closing price of $1.18. In other words, the price has decreased by -$4.24 from its previous closing price. On the day, 2.11 million shares were traded. ALLO stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.12.

Ratios:

For a deeper understanding of Allogene Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.71 and its Current Ratio is at 9.71. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.

On March 14, 2025, Citizens JMP Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $5.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 10 ’25 when MESSEMER DEBORAH M. sold 36,885 shares for $1.42 per share. The transaction valued at 52,377 led to the insider holds 107,431 shares of the business.

MESSEMER DEBORAH M. bought 36,885 shares of ALLO for $52,391 on Jun 10 ’25. On Apr 21 ’25, another insider, Yoshiyama Annie, who serves as the SVP, Finance of the company, sold 9,601 shares for $1.41 each. As a result, the insider received 13,537 and left with 130,663 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 258102160 and an Enterprise Value of 56045816.

Stock Price History:

The Beta on a monthly basis for ALLO is 0.32, which has changed by -0.47685188 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $3.78, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -13.65%, while the 200-Day Moving Average is calculated to be -42.41%.

Shares Statistics:

For the past three months, ALLO has traded an average of 3.12M shares per day and 2569320 over the past ten days. A total of 218.60M shares are outstanding, with a floating share count of 149.51M. Insiders hold about 31.65% of the company’s shares, while institutions hold 66.03% stake in the company. Shares short for ALLO as of 1749772800 were 26041918 with a Short Ratio of 8.36, compared to 1747267200 on 27361306. Therefore, it implies a Short% of Shares Outstanding of 26041918 and a Short% of Float of 14.42.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.